Xiaolong Meng

1.2k total citations
11 papers, 914 citations indexed

About

Xiaolong Meng is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Xiaolong Meng has authored 11 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Nutrition and Dietetics. Recurrent topics in Xiaolong Meng's work include Vitamin C and Antioxidants Research (3 papers), Cancer Research and Treatments (2 papers) and Vitamin D Research Studies (2 papers). Xiaolong Meng is often cited by papers focused on Vitamin C and Antioxidants Research (3 papers), Cancer Research and Treatments (2 papers) and Vitamin D Research Studies (2 papers). Xiaolong Meng collaborates with scholars based in United States, Canada and United Kingdom. Xiaolong Meng's co-authors include Neil H Riordan, Jie Zhong, Thomas E. Ichim, James Jackson, Vladimir Bogin, Hao Wang, Wei Ge, Bernard Thébaud, Kyle Chan and Hugh D. Riordan and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Cancer and Metastasis Reviews.

In The Last Decade

Xiaolong Meng

11 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Meng United States 9 311 249 220 158 148 11 914
George T. Tkalcevic United States 13 684 2.2× 33 0.1× 105 0.5× 38 0.2× 70 0.5× 14 1.3k
Majid Farshdousti Hagh Iran 20 733 2.4× 202 0.8× 71 0.3× 17 0.1× 130 0.9× 57 1.1k
Steven L. Smock United States 15 608 2.0× 38 0.2× 64 0.3× 40 0.3× 107 0.7× 17 1.1k
Svetislav Tatić Serbia 18 321 1.0× 43 0.2× 186 0.8× 32 0.2× 257 1.7× 75 962
Dahui Sun China 15 415 1.3× 104 0.4× 108 0.5× 92 0.6× 112 0.8× 39 937
Federica Maccarinelli Italy 19 393 1.3× 238 1.0× 29 0.1× 178 1.1× 91 0.6× 34 1.0k
Paz de la Torre Spain 17 302 1.0× 156 0.6× 132 0.6× 15 0.1× 91 0.6× 31 816
Anne-Marie Byrne Ireland 12 598 1.9× 69 0.3× 161 0.7× 11 0.1× 225 1.5× 16 1.2k
Lixin Liu China 19 690 2.2× 155 0.6× 338 1.5× 17 0.1× 132 0.9× 59 1.3k

Countries citing papers authored by Xiaolong Meng

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Meng more than expected).

Fields of papers citing papers by Xiaolong Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Meng. The network helps show where Xiaolong Meng may publish in the future.

Co-authorship network of co-authors of Xiaolong Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Meng. A scholar is included among the top collaborators of Xiaolong Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Meng. Xiaolong Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liu, Shuying, Xiaolong Meng, Huiqin Chen, et al.. (2014). Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer. Oncotarget. 5(19). 9049–9064. 20 indexed citations
3.
Raghav, Kanwal, Wenting Wang, Shuying Liu, et al.. (2012). cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes. Clinical Cancer Research. 18(8). 2269–2277. 108 indexed citations
4.
Meng, Xiaolong, et al.. (2011). A new hypothesis for the cancer mechanism. Cancer and Metastasis Reviews. 31(1-2). 247–268. 39 indexed citations
5.
Han, Xiaodi, Xiaolong Meng, Jie Zhong, et al.. (2009). Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle. 8(4). 606–610. 40 indexed citations
6.
Meng, Xiaolong, Thomas E. Ichim, Jie Zhong, et al.. (2007). Endometrial regenerative cells: A novel stem cell population. Journal of Translational Medicine. 5(1). 57–57. 473 indexed citations
7.
Meng, Xiaolong & Neil H Riordan. (2005). Cancer is a functional repair tissue. Medical Hypotheses. 66(3). 486–490. 26 indexed citations
8.
Riordan, Hugh D., Neil H Riordan, Xiaolong Meng, et al.. (2003). Intravenous ascorbic acid: protocol for its application and use.. PubMed. 22(3). 287–90. 35 indexed citations
9.
Casciari, Joseph J, Neil H Riordan, Thorsten Schmidt, et al.. (2001). Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. British Journal of Cancer. 84(11). 1544–1550. 80 indexed citations
10.
Riordan, Neil H, et al.. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Medical Hypotheses. 44(3). 207–213. 86 indexed citations
11.
Meng, Xiaolong, et al.. (1994). Improved microplate fluorometer counting of viable tumor and normal cells.. PubMed. 14(3A). 927–31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026